Skip to main content
G1 Therapeutics, Inc. (GTHX)
Sep 18, 2024 - GTHX was delisted (acquired by Pharmacosmos)
7.15
0.00 (0.00%)
Inactive · Last trade price on Sep 17, 2024

G1 Therapeutics Revenue

G1 Therapeutics had revenue of $16.55M in the quarter ending June 30, 2024, a decrease of -60.97%. This brings the company's revenue in the last twelve months to $58.20M, down -34.73% year-over-year. In the year 2023, G1 Therapeutics had annual revenue of $82.51M with 60.84% growth.

Revenue (ttm)
$58.20M
Revenue Growth
-34.73%
P/S Ratio
6.40
Revenue / Employee
$581,950
Employees
100
Market Cap
378.17M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202382.51M31.21M60.84%
Dec 31, 202251.30M19.83M62.98%
Dec 31, 202131.48M-13.81M-30.49%
Dec 31, 202045.29M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

GTHX News

More News